SCOPE 2 – Still Answering the Unanswered Questions in Oesophageal Radiotherapy? SCOPE 2: a Randomised Phase II/III Trial to Study Radiotherapy Dose Escalation in Patients with Oesophageal Cancer Treated with Definitive Chemoradiation with an Embedded Phase II Trial for Patients with a Poor Early Response using Positron Emission Tomography/Computed Tomography

التفاصيل البيبلوغرافية
العنوان:	SCOPE 2 – Still Answering the Unanswered Questions in Oesophageal Radiotherapy? SCOPE 2: a Randomised Phase II/III Trial to Study Radiotherapy Dose Escalation in Patients with Oesophageal Cancer Treated with Definitive Chemoradiation with an Embedded Phase II Trial for Patients with a Poor Early Response using Positron Emission Tomography/Computed Tomography
المؤلفون:	Bridges, S. ^{∗, 1}, Thomas, B. ^{†, 1}, Radhakrishna, G. ^‡, Hawkins, M. ^§, Holborow, A., Hurt, C. ^∗, Mukherjee, S. ^\|\|, Nixon, L. ^{∗, 2}, Crosby, T. ^{†, 2}, Gwynne, S. ^{¶, ∗∗, 2}
المصدر:	In Clinical Oncology July 2022 34(7):e269-e280
قاعدة البيانات:	ScienceDirect

الوصف
تدمد:	09366555
DOI:	10.1016/j.clon.2022.03.019